跳至主要内容
临床试验/ISRCTN16613220
ISRCTN16613220已完成未知

Antenatal dexamethasone regimen in mild gestational diabetes: A Randomized controlled trial

niversity Malaya0 个研究点目标入组 60 人开始时间: 2018年2月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

2021 results in https://pubmed.ncbi.nlm.nih.gov/33452923/ (added 18/01/2021)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. All antenatal cases with mild gestational diabetes mellitus between 24-38 weeks who are planned for antenatal dexamethasone for improvement of neonatal outcome. Gestational diabetes mellitus defined as 75 g oral glucose tolerance test (OGTT) of fasting blood glucose = 5.1 mmol/l or a 2 hours post prandial glucose = 7.8 mmol/l (American Diabetes Association 2016 guidelines). A mild case of gestational diabetes is defined as a patient adequately controlled glycaemic status without the for need oral hypoglycaemic agent or insulin.
  • 2. Age more than 18 years old
  • 3. Singleton pregnancy
  • 4. Viable pregnancy

排除标准

  • 1. Patients on hypoglycaemic agent or insulin
  • 2. Pre-existing Type 1 or Type 2 diabetes mellitus
  • 3. Baseline capillary blood glucose level more than 11mmol/L (at recruitment)
  • 4. Patients in active labour or likely to deliver within the next 24 hours after administration of antenatal dexamethasone
  • 5. Evidence of chorioamnionitis or other maternal or fetal infection
  • 6. Patients on terbutaline or other beta-mimetic agents
  • 7. Diet restricted in anticipation of imminent Caesarean birth

研究者

发起方
niversity Malaya

相似试验